Market Research Reports, Analysis, Trends and Forecast

Global Hydrogen Breath Test Analyzer Market is estimated to value over USD 37 Million by 2029 end and register a CAGR of over 3.5% during the forecast period, 2019 to 2029. 

Global Actinic Keratosis Treatment Market is calculated to value over USD 8.5 Billion by 2029 end and register a CAGR of over 4% from 2019 to 2029

Actinic keratosis is mainly observed in regions with a thin ozone layer as it is caused by prolonged exposure to dangerous UV rays which can result into squamous cell carcinoma. It is mainly observed in men and around 20% of patients with injuries from actinic keratosis create dangerous squamous cell carcinoma.

The Intravitreal (IVT) injectables market is poised to value over USD 5 billion by 2029 end. 

Intravitreal (IVT) injectables are immensely prevalent among eye specialists. Anti–vascular endothelial growth factor (anti-VEGF) drugs are primarily used for treating macular degeneration, retinal vein occlusion, diabetic retinopathy and others. Rising prevalence of these diseases has expanded the anti-VEGF market assisting the growth of global IVT market.

Atherectomy Devices Market is estimated to value over USD 2.4 Billion by 2029 end and register a CAGR of over 6.5% during the forecast period 2019 to 2029 

A growing preference for non-invasive procedures and an increasing prevalence of target diseases are some of the crucial aspects that drive the market. Furthermore, an increase in the geriatric population, the rising number of peripheral artery diseases (PAD) patients propel market growth. However, lack of skilled surgeons who can handle such non-invasive procedures can impede the market growth significantly.

The spinal stenosis implants market is calculated to register a CAGR of over 5.8% during the forecast period of 2019 to 2029. 
Spinal stenosis, which is the irregular narrowing of the spinal canal, is prominently observed in elderly patients. Some of its symptoms are numbness in legs, lower back pain and problem in balancing the body. A rise in the geriatric population is the key factor responsible for substantial market growth.

lateral flow assay market envisioned to value over US$ 9.7 Billion by 2029 end and register a CAGR of over 6.9% from 2019 to 2029.

Lateral flow assay is used to ratify pathogens or biomarkers in animals and humans. It's mostly used in human health and in medical diagnostics for laboratory use and home testing. Increase in disposable income and rising geriatric population are expected to fuel the growth of the market. Increase demand for home pregnancy tests is also boosting the growth of the market. 

Neurovascular thrombectomy devices market value over USD 3 billion by 2029 end and register a CAGR of over 6.6% from 2019 to 2029.

Neurovascular thrombectomy devices are mainly employed in the arteries, veins, and capillaries to diffuse blood clots while causing minimal damage and blood loss. Diseases such as acute myocardial infarction, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions.

Injectable nanomedicines market to value over USD 400 Million by 2029 end and register a CAGR of over 8% from 2019 to 2029. 

Substantial research and advancements in technology for drug development have given a significant boost in the global injectable nanomedicines market. Globally, the increase in use of liposomal drugs and growing patient population has fueled demand for injectable nanomedicines. Developing application of nanomedicines in the medical sector and therapeutics is further augmenting the demand of the global market.

Sleeping Aids Market is estimated to value over USD 115 Billion by 2029 end and register a CAGR of over 6.5% during the forecast period 2019 to 2029. 
Stressful lifestyles have reduced the amount of sleeping time an average person needs resulting in sleep disorders like insomnia, sleep apnea and mental disorders like depression and nervous breakdown. These are some of the crucial factors responsible for the significant growth of the sleep aids market globally.

The Triple-negative breast cancer treatment market is forecasted to value over US$ 820Million by 2029 end and register a CAGR of over 4.5% from 2019 to 2029.
Triple-negative breast cancer is a type of cancer that does not have any receptors for hormones progesterone and estrogen. Triple-negative breast cancer does not respond to hormonal therapy and requires combines surgery.

Immune checkpoint inhibitors market value over USD 26 Billion by 2029 end and register a CAGR of over 13.6% from 2019 to 2029.

Immune checkpoint inhibitors are drugs used in advanced-stage cancers. These drugs work on the immunity of the body and the mechanism is to develop the patient’s body immunity to recognise, fight and annihilate the disease-causing bacteria or virus. Unlike other therapies, instead of attacking the tumour, this trains the body and it’s immunity to fight and protect the body from ailments.

Elder Care Services Market is estimated to value over USD 2.1 Billion by 2029 end and register a CAGR of over 6.3% during the forecast period 2019 to 2029. 
A rising number of geriatric patient population suffering from disabilities is one of the primary influential factors that drive the global elder care services market. Additionally, government-supported agencies, organizations associated with non-profit hospitals and independent charitable groups play a crucial role in the sustainability of the elder care services market. 

Insomnia treatment market to value over USD 5.8 Billion by 2029 end and register a CAGR of over 5.2% from 2019 to 2029.

The growing cases of insomnia worldwide due to rising stress levels has led to the growth of this market. With rising geriatric population coupled with awareness about numerous therapies and treatments in the market, support and propel the market’s growth.

Robotic surgery system market to value over USD 6 Billion by 2029 end and register a CAGR of over 10% from 2019 to 2029.

Robotic surgery systems are an evolvement of medical sciences due to advancements in technology. Complex procedures are carried out with more accuracy, attention to detail and flexibility thus making it the preferable alternative over conventional traditional methods. 

Feminine hygiene products market to value over USD 37.5 Billion by 2029 end and register a CAGR of over 9% from 2019 to 2029. 

Major factors contributing to the robust growth of the global feminine hygiene products market are increased awareness about hygiene and sanitization and increasing purchasing power due to a rise in the disposable income. Rising awareness and environmental concern have opened up new avenues in the market for manufacturers to venture into and pursue. Thus the market for cloth sanitary pads and pads made from organic materials & biodegradable products witnesses high demand. This a fairly untapped sector and gives manufacturers to garner revenue through innovation and sale of premium products. 

Breast implants market to value over USD 2.4 Billion by 2029 end and register a CAGR of over 6% from 2019 to 2029. 

Mounting consciousness about physical appearance as well as technological advancements has helped the global breast implant market to grow. Breast implants are employed to augment the shape and size of breasts. Due to soaring innovations, the next-generation of breast implants are highly sought after due to their lightweight nature as compared to the traditional breast implants.

Lithotripsy Devices Market is assessed to value over US$ 1.9 Billion by 2029 and register a CAGR of over 4.3% from 2019 to 2029.
Lithotripsy is the medical process of breaking down of kidney stones present in the kidney and other organs such as liver or gallbladder. Kidney stones, in general exit the body through urination but at times the body cannot pass large stones and it could cause severe pain, urinary tract infections, and bleeding. Therefore, breaking stones is necessary. After the breaking down of stones, the tiny pieces of stones exit the body through the urine. 

Histopathology testing equipment market is envisioned to value over US$ 8 Billion by 2029 end and register a CAGR of over 4% from 2019 to 2029.
Histopathology is the perusal of tissues from the body with the help of a microscope and the signs and characteristics of the disease can be spotted. The histopathology testing equipment tools are utilized for the perusal of tissues and preparing samples.

Syringes and cannulas market is envisioned to value over US$ 24.5 Billion by 2029 end and register a CAGR of over 4% from 2019 to 2029.

Rising surgeries alongside a growing pool of patients are accelerating the growth of the market. Since the healthcare industry requires syringes and cannulas in bulk, multiple local manufacturers have appeared to fulfil the bulk supply with affordable rates. This has inflated the size of the market. 

Fetal and Neonatal Care Equipment Market is estimated to value over USD 9 Billion by 2029 end and register a CAGR of over 5% during the forecast period 2019 to 2029. 

There has been a rapid rise in the birth rate worldwide. Additionally, there has been an increase in the number of premature births which increases demand for devices that can be utilized to reduce the fetal mortality rate. Increasing awareness regarding neonatal infant care is an integral factor which can assist the market to grow globally.

Airway or Lung Stents Market is estimated to value over USD 125 Million by 2029 end and register a CAGR of over 6.2% during the forecast period 2019 to 2029. 

Airway or lung stent is inserted into an airway to replace the damaged one to ensure that the lungs function normally. The lung stent market is gaining significant traction owing to a rise in the geriatric population and the rapid adoption of lung stents in order to treat various chronic lung diseases.

Hemato Oncology Testing Market is estimated to value over USD 4.6 billion by 2029 end and register a CAGR of over 13.8% during the forecast period 2019 to 2029. 

The type of product and service, the global hemato oncology market is bifurcated into services segment and assay kits segment.
Based on the type of cancer, the market is categorised as leukaemia, acute myeloid leukaemia, acute lymphocytic leukaemia, lymphoma, non-hodgkin lymphoma, hodgkin lymphoma and others. As leukaemia patients require continuous monitoring and considering the ever-increasing number of leukaemia cases worldwide, this segment is anticipated to dominate the market during the forecast period.

Track and Trace Solutions Market is estimated to value over USD 4.5 billion by 2029 end and register a CAGR of over 14% during the forecast period 2019 to 2029. 

Tack and trace solutions are implemented to monitor supply chains by major biopharmaceutical and pharmaceutical companies in order to curb down drug counterfeiting. Drug counterfeiting ranges from something relatively harmless as misleading medication with an intent to duplicate an authentic and approved product to the dangerous practice of selling medication consisting of an excess or insufficient amount of active ingredient. But using track and trace solutions, this obstacle can be eliminated to a very large extent.